shortagewatch

Home / Nervous system / Levodopa, Decarboxylase Inhibitor and COMT Inhibitor

ATC N04BA03 · Anti-Parkinson Drugs

Levodopa, Decarboxylase Inhibitor and COMT Inhibitor shortage

As of 31 Oct 2026, Levodopa, Decarboxylase Inhibitor and COMT Inhibitor has a reported shortage in 2 of the 5 countries we track (Italy, Spain), covering 4 products.

Countries2/5
Products4packs or presentations
Short since8 Oct 202623 days ago
Earliest return26 Nov 2026company estimate
No return date2products
Main reasonManufacturing problem
GermanyNo reported shortageItaly2 packs shortSpain2 packs shortAustriaNo reported shortageBelgiumNo reported shortage

Timeline

ItalySpain
2027LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 100 MG/2LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 100 MG/25 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidosLEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 10LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 100 mg/25 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidostoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITLEVODOPA/CARBIDOPA/ENTACAPONE MYLAN announcedMYLAN S.P.A.1 Jan 2027not givenManufacturing problem
Problemi produttivi
ITLEVODOPA/CARBIDOPA/ENTACAPONE MYLAN announcedMYLAN S.P.A.1 Jan 2027not givenManufacturing problem
Problemi produttivi
ESLEVODOPA/CARBIDOPA/ENTACAPONA CINFA 100 MG/25 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidosLaboratorios Cinfa S.A.8 Oct 202626 Nov 2026Not stated
ESLEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 100 mg/25 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidosKern Pharma S.L.8 Oct 20262 Dec 2026Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.